HYBRID EVENT: Join us in person in Singapore or attend virtually from anywhere.

3rd Edition of International Cancer & Immuno-Oncology Conference

March 15-17, 2027 | Singapore
March 15-17, 2027 | Singapore

Wilms Tumor

Wilms Tumor

Wilms tumor, a rare kidney cancer primarily affecting children, presents a unique challenge in cancer research. Researchers are exploring various aspects to understand its etiology and improve treatment outcomes. Genomic studies have identified mutations in genes like WT1 and CTNNB1, shedding light on the tumor's genetic basis. Advances in imaging technologies aid in early detection, crucial for successful treatment. Additionally, targeted therapies, such as those inhibiting angiogenesis or exploiting specific molecular pathways, offer promising avenues. Immunotherapy, harnessing the body's immune system to fight cancer cells, is also being investigated. Collaborative efforts between oncologists, geneticists, and immunologists are crucial in unraveling Wilms tumor's complexities and devising effective therapeutic strategies. Through interdisciplinary research, the aim is to enhance survival rates and quality of life for children battling this challenging malignancy.

Committee Members
Committee Member - Michael Thompson

Michael Thompson

University of Toronto, Canada
Committee Member - Pietro Salvatori

Pietro Salvatori

Formerly, Humanitas San Pio X Hospital, Italy
Committee Member - Rajvir Dahiya

Rajvir Dahiya

University of California San Francisco, United States

Submit your abstract Today

YouTube
WhatsAppWhatsApp